TGFB1 and pulmonary fibrosis: FOXO4-DRI eliminates TGFβ-induced myofibroblasts in vitro and prevents bleomycin-induced pulmonary fibrosis and increases AT2 cell regeneration in mice (Han et al, 2022; Liu et al, 2023b).